Delfi - RHB Invest 2024-03-18: Positive On Growth Amid Lower Margins; Keep BUY

Delfi - Positive On Growth Amid Lower Margins; Keep BUY

Published:
Delfi (SGX:P34) | SGinvestors.ioDelfi (SGX:P34)
  • We maintain BUY on Delfi (SGX:P34), due to its compelling valuation and earnings growth outlook which, in turn, is based on the recovery in regional consumption and Indonesia’s rising middle-income segment.
  • - Read this at SGinvestors.io -

FY23 revenue and core operating profit were lower than estimated.

  • Delfi’s FY23 revenue of US$538m (+13% y-o-y) and operating profit of US$64m (+2% y-o-y) were below estimates. Headline earnings were, however, in line at US$46m (+5% y-o-y) lifted by lower effective taxes and higher-than-expected non-operating income.
  • - Read this at SGinvestors.io -
  • Its operating profit margin (12%) as a result, was below our forecast of 13%.
  • Delfi declared final and special dividends of 1.74 and 0.52 US$ cents, which brings full year dividend to 4.32 US$ cents, amounting to a dividend payout ratio of ~57%.

Cut FY24-25F earnings by 11-12%

  • Read more at SGinvestors.io.



Above is an excerpt from a report by RHB Securities Research.
Clients of RHB may be the first to access the full PDF report @ https://www.rhbtradesmart.com/.



Alfie Yeo RHB Securities Research | https://www.rhbgroup.com/ 2024-03-18



Read also RHB's most recent report:
2024-04-09 Delfi - Expect Minimal Margin Pressure; Keep BUY.

Price targets by other brokers at Delfi Target Prices.

Listing of research reports at Delfi Analyst Reports.

Relevant links:
Delfi Share Price History,
Delfi Announcements,
Delfi Dividend Payout Dates & Corporate Actions,
Delfi News





Advertisement

You May Also Like




SGX Stock / REIT Search

Advertisement

Most Read

Trust Bank Referral Code

Advertisement